Region
Featured experience
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
iQIYI $350 million convertible notes offering and concurrent private repurchases
We advised iQIYI on the transactions
Shuifa Group $200 million bonds offering
We advised the joint lead managers on the Regulation S bonds offering
China South City Holdings $50 million high-yield notes reopening
We advised the initial purchaser on the Regulation S offering
Tuya $915 million IPO
We advised Tuya on its IPO and NYSE listing
Fujian Yango $50 million high-yield notes offering
We advised the joint lead managers on the Regulation S offering
China South City Holdings $175 million high-yield notes offering
We advised the initial purchasers on the offering
I-Mab $177 million follow-on secondary offering of ADSs
We advised the underwriters on the equity offering
JOINN Laboratories HK$6.5 billion IPO
We advised JOINN Laboratories on its IPO and HKEX listing.
Victory for PwC China in putative class action
We secured a complete dismissal for PwC China in a lawsuit by Gridsum Holding shareholders
Fantasia $150 million high-yield notes reopening and concurrent tender offer
We advised the initial purchasers on the offering and the dealer managers on the tender offer for Fantasia’s senior notes
InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares